AstraZeneca is paying $160 million for FibroGen’s China business, giving the U.K.-based Big Pharma the regional rights to ...

ASX health stocks up in what Morgans analyst Scott Power describes as mixed earnings report season as Mayne surges on $672 ...

Zealand’s CEO Adam Steensberg said that the company is “exactly where it wants to be” in terms of its partnering and ...

Travis Coy is using his Big Pharma bona fides to prioritize business development at the diversified and growing company.

We recently published a list of the 12 Most Oversold Healthcare Stocks to Buy Now. In this article, we are going to take a ...

Microba Life Sciences (ASX:MAP), which has technology for measuring the gut microbiome, has a strategic partnership deal with ...

Elon Musk has reacted to J.D. Vance's Joe Rogan Experience (JRE) conversation, wherein Vance explained what changed his mind ...

In this edition of “Psychedelic”, The Fly conducted an exclusive interview with Joseph Tucker, Chief Executive Officer and Director of Enveric ...

Companies argue they’re filling a need created by these miracle weight-loss drugs. But are they offering something of real ...

We recently published a list of the 12 Most Oversold Healthcare Stocks to Buy Now. In this article, we are going to take a ...